Eyonis® is a suite of Software as a Medical Device (SaMD) that leverages advanced Data Science (DS) & Artificial Intelligence (AI) technologies to analyze medical imaging, supporting radiologists & other healthcare professionals in identifying cancers at the earliest stage, even when invisible to the human eye. Our flagship product, eyonis® LCS, is an AI/ML tech-based end-to-end Computer-Assisted detection & diagnosis (CADe/CADx) SaMD developed to aid cancer diagnosis and improve clinical management of patients, designed to enable early detection, localization and characterization of lung nodules on chest CT images. eyonis® LCS is FDA-cleared & CE-marked in 2026, available for commercial sales in the US & EU markets.
| Website | https://eyonis.ai/ |
| Employees | 23 (11 on RocketReach) |
| Founded | 2020 |
| Industry | Hospitals and Health Care |
Looking for a particular Eyonis, Inc. employee's phone or email?
Oran Muduroglu is the Executive Chairman and President of Eyonis, Inc..
11 people are employed at Eyonis, Inc..
Eyonis, Inc. is based in San Francisco, California.